00:02What is the most important thing about genetics and genomics?
00:09Genes, Genes, Genes
00:11We are talking about a basis on a basis on a basis on a basis on a basis on a
00:17basis on a basis on a basis
00:29Genome sequencing, your body, and body's body that is almost a basis on a basis on a basis on a
00:36basis on a basis on a basis on a basis on a basis on a basis of this basis
00:41Now there is what happens next to the model, nod, and right than the present,
00:59I will start a research collaboration with a research
01:04What is the result of the treatment?
01:06How many people have been there?
01:09Why are they complications?
01:12Why are they controlling the treatment?
01:18Why are they going to get the treatment?
01:18If they are the result of the treatment, they will be able to use insulin
01:22But if they are the result of insulin, they will be able to use insulin
01:25This is a genetic test
01:34We will do the same thing as we can do genetic tests.
01:40For example, there are type 1 diabetes, type 2 diabetes, type 5 diabetes, maturity onset of young, modi, and that
01:51is one type of diabetes.
01:51We will do the same thing as a blood test.
01:55We will do genomic testing.
01:57Genomics is one facility.
02:00That is also proteomics.
02:02If the gene is done, we will study protein.
02:07That is also epigenetics.
02:10That is also epigenetics.
02:21That is not our job.
02:23That is also epigenetics.
02:25So we will study multiomics.
02:27Genomics, proteomics, transcriptomics, multiomics.
02:30All of these are the same.
02:31In India, we will start a diabetic center.
02:45We will start 30 research projects.
02:49And international collaboration is also coming.
02:53Nationally, we also work with all the institutes.
02:56All India Institute of Medical Sciences, CDC, Delhi, Nimhans, Bangalore.
03:03We also work with all the institutes.
03:05National Institute of Nutrition, Hyderabad.
03:07We work with all the institutes.
03:19All of these are the same ideas.
03:28Sir, what is the difference between your staff?
03:34We have done a piecemeal.
03:39We have done a gene.
03:42We have done a gene.
03:44We study the gene.
03:45We have studied the gene.
03:47We will miss the gene.
03:48But we will miss the gene.
03:50Regarding the whole genome,
03:51All the genes, the whole genetic gene.
03:55We have done a gene over time.
03:57But there is an advantage of what we have done.
04:00Sometimes, we will try to have the gene.
04:03In fact, this type 2 diabetes gene is Tcf-7L2.
04:13One gene.
04:15The gene is not the same thing.
04:21It is the same thing.
04:23It is the same thing.
04:25It is the same thing.
04:26So, if we go to fixed ideas,
04:29we may be wrong.
04:33We may be completely wrong.
04:35That's why AI is able to do better than us.
04:38Because we have experience
04:39and we can do this.
04:41Of course, 80% is correct or 90% is correct.
04:44If we could be wrong,
04:46If we do a whole genome study,
04:50we can do different genes.
04:52Which we never thought of at all.
04:54That is the advantage.
04:55That is something new.
04:56We can do it.
04:59This is not a test.
05:01This is not a test
05:03commercially.
05:04If a patient comes to the test,
05:08we can do treatment.
05:09This is not a test.
05:11Actually, we can do it.
05:13We can do it completely free of cost.
05:18Of course,
05:19In a particular institution,
05:21if you want to do it in Bombay,
05:22or Calcuttural,
05:24you can study the cost.
05:29We will not be able to do it completely free.
05:31If you do it,
05:32if you want to do it,
05:33but if you want to do it,
05:36we will have to charge.
05:37But we will be competitive.
05:38If you want to do it in the market,
05:40we will be competitive.
05:41We don't want to make money out of this.
05:43We want to service people.
05:45Because equipment is available.
05:47Time is over.
05:51Then we will do it at cost price or some.
05:55But not for the patient.
05:57This is not a commercial project at all.
05:59Patient will not pay anything for this.
Comments